Læknablaðið - 15.11.1991, Qupperneq 40

362
LÆKNABLAÐIÐ
5. Fedson DS. Pneumococcal vaccine. In: Plotkin SA,
Mortimer EA, eds. Vaccines. Philadelphia: WB
Saunders, 1988: 271-99.
6. LaForce FM, Eickhof TC. Pneumococcal vaccine:
an emerging consensus. Ann Intem Med 1988; 108:
757-9.
7. Shapiro EÐ, Clemens JD. A controlled evaluation
of the protective efficacy of pneumococcal vaccine
for patients at high risk of serious pneumococcal
infections. Ann Intem Med 1984; 101: 325-30.
8. Shapiro ED, Austrian R, Adair RK, Clemens JD.
The protective efficacy of pneumococcal vaccine
(Abstract). Clin Res 1988; 36: 470A.
9. Sims RV, Steinmann WC, McConville JH, King LR.
Zwick WC, Schwartz JS. The clinical effectiveness
of pneumococcal vaccine in the elderly. Ann Intem
Med 1988; 108: 653-7.
10. Farr BM, Cobb DK, Johnston BL, Tucker
SI, Germanson T, Fisch MJ. A case control
study of pneumococcal vaccine (PV) efficacy
in preventing pneumococcal bacteremia (PB).
Program and Abstracts of the Twenty-Ninth
Interscience Conference on Antimicrobial Agents
and Chemotherapy. Houston, Texas: The American
Society for Microbiology, 1989; 174 (Abstract).
11. Bolan G, Broome CV, Facklam RR, Plikaytis BD,
Fraser DW, Sclech WF III. Pneumococcal vaccine
efficacy in selected populations in the United States.
Ann Intem Med 1986: 104: 1-6.
12. Gable CB, Holzer SS, Engelhart L, et al.
Pneumococcal vaccine: efficacy and associated cost
savings. JAMA 1990; 264: 2910-15.
13. Gaillat J, Zmirou D, Mallaret MR, et al. Essai
clinique du vaccin antipneumococcique chez des
personnes ágées vivant en institution. Rev Epidemiol
Sante Publique 1985; 33: 437-44.
14. Makela H, Jokinen C, Pyhálá R, Mákelá M, Ruutu P.
Use of vaccines for respiratory infections: strategies
for influenza and pneumococcal vaccines. Scan J Inf
Dis. In press.
15. Dreifibréf landlæknisembættisins nr. 4/1991.
Læknablaðið/Fréttabréf lækna 1991; 9(5): 12-3.